Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Tazarotene - Ortho Dermatologics

Next Previous
Drug Profile

Tazarotene - Ortho Dermatologics

Alternative Names: ARAZLO; IDP-123

Latest Information Update: 26 Dec 2022

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Valeant Pharmaceuticals International
  • Developer Bausch Health Companies
  • Class Anti-inflammatories; Antiacnes; Antifibrotics; Antipsoriatics; Esters; Keratolytics; Nicotinic acids; Pyrans; Pyridines; Retinoids; Small molecules
  • Mechanism of Action Retinoic acid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Acne vulgaris

Most Recent Events

  • 22 Dec 2022 Launched for Acne vulgaris (In adolescents, In children, In the elderly, In adults) in Canada (Topical)
  • 05 Aug 2021 9331373: Approval info added, KDM updated, advanced dev line, intro updated
  • 04 Aug 2021 Preregistration for Acne vulgaris (In adolescents, In children, In the elderly, In adults) in Canada (Topical), prior to August 2021

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top